Prelude Therapeutics (PRLD) Enterprise Value Growth (1y) (2020 - 2026)
Prelude Therapeutics (PRLD) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-40.23% |
| Dec 31, 2025 |
25.02% |
| Sep 30, 2025 |
63.09% |
| Jun 30, 2025 |
32.15% |
| Mar 31, 2025 |
49.93% |
| Dec 31, 2024 |
41.91% |
| Sep 30, 2024 |
32.78% |
| Jun 30, 2024 |
29.01% |
| Mar 31, 2024 |
-16.83% |
| Dec 31, 2023 |
-15.17% |
| Sep 30, 2023 |
-2.83% |
| Jun 30, 2023 |
-3.47% |
| Mar 31, 2023 |
34.76% |
| Dec 31, 2022 |
30.31% |
| Sep 30, 2022 |
28.91% |
| Jun 30, 2022 |
27.04% |
| Mar 31, 2022 |
25.55% |
| Dec 31, 2021 |
-35.26% |
| Sep 30, 2021 |
-36.66% |
| Dec 31, 2020 |
-1,056.36% |
